Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
55
Number of overlapping holdings
24.6%
% of IBB's 261 holdings also in BBP
90.2%
% of BBP's 65 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.2% | 2.1% | 2.1% |
|
AMGEN INC | 8.4% | 2.0% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 8.6% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 1.6% | 1.6% |
|
BEIGENE LTD. SPONSORED ADR | 1.6% | 2.3% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to BBP
|
VERTEX PHARMACEUTICALS INC | 6.9% |
|
AMGEN INC | 6.4% |
|
GILEAD SCIENCES INC | 6.1% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
IQVIA HOLDINGS INC | 3.4% |
 |
ARGENX SE ADR | 2.7% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
WATERS CORP | 2.3% |
|
NATERA INC | 2.0% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% |
IBB Underweight Relative to BBP
|
SAGE THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -1.9% |
|
SPRINGWORKS THERAPEUTICS, INC. | -1.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.7% |
|
ARDELYX INC | -1.7% |
|
DYNAVAX TECHNOLOGIES CORP | -1.6% |
|
AXSOME THERAPEUTICS, INC. | -1.6% |
|
IMMUNITYBIO INC | -1.6% |